Suchergebnisse - "Hirakawa, K"

PubPharm (698)

1

Time-to-onset of diabetes with everolimus use: analysis of a spontaneous reporting system database

enthalten in: Die Pharmazie | 2023

von Ohyama, K. | Hirakawa, K. | Sasazaki, K. | +3

2

Time-to-onset of diabetes with everolimus use : analysis of a spontaneous reporting system database

enthalten in: Die Pharmazie | 2021

von Ohyama, K. | Hirakawa, K. | Sasazaki, K. | +3

3

Vacuum-field-induced THz transport gap in a carbon nanotube quantum dot

enthalten in: Nature communications | 2021

von Valmorra, F. | Yoshida, K. | Contamin, L. | +14

4

Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy

enthalten in: BJS open | 2019

von Takada, K. | Kashiwagi, S. | Fukui, Y. | +6

5

Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer

enthalten in: Biomarker Research | 2018

von Goto, W. | Kashiwagi, S. | Asano, Y. | +9

6

Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer

enthalten in: Biomarker Research | 2018

von Goto, W. | Kashiwagi, S. | Asano, Y. | +9

7

Thermionic cooling devices based on resonant-tunneling AlGaAs/GaAs heterostructure

enthalten in: Journal of physics. Condensed matter : an Institute of Physics journal | 2018

von Bescond, M. | Logoteta, D. | Michelini, F. | +5

8

Correction to : Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer

enthalten in: Biomarker research | 2018

von Goto, W. | Kashiwagi, S. | Asano, Y. | +9

ErratumFor: Biomark Res. 2017 May 12;5:19. - PMID 28507762

9

Abstract P6-09-25: Circulating tumor cell clusters-associated gene plakoglobin is a novel prognostic predictor in patients with breast cancer

enthalten in: Cancer research | 2017

von Goto, W. | Kashiwagi, S. | Asano, Y. | +8

10

Abstract P2-05-05: Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB)

enthalten in: Cancer research | 2017

von Asano, Y. | Kashiwagi, S. | Goto, W. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[70]